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Abstract
For the purpose to reveal the metabolic pathway of GABOB the analyses were performed with
the GABOB containing fluid perfused through the liver and the brain of rabbits, and the following
results were obtained. Qualitative observations by paperchromatography on the fluid containing
GABOB after perfusing the organs proved the presence of some amino acids. These were iden-
tified as glycine, glutamic acid and glutamine. The observation on the GABOBcontaining fluid
perfused the organs showed a decrease in GABOB and an increase in these amino acids. Quanti-
tative observation proved a considerable increase in glycive and a moderate increase in glutamic
acid and glutamine with a marked decrease in the amount of GABOB injected. From these results
it is believed that GABOB is decomposed into glycine and acetic acid probably passing the stage
of γ-aminoacetoacetic acid in one way and into glutamic acid by the transamination of GABOB
with α-ketoglutaric acid in the other.
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In the previous experiment using the human and rabbits brains, the authorl
suggested that the oxygen consumption of brain is not so closely correlated with
r-amino-p-hydroxybutyric acid (GABOB), but there is a possibility that the de-
crease in GABOB contents in epileptic brain by the accelerated decomposition
with its raised oxygen consumption may be correlated to the epileptic attack.
This time the author observed the disintegration of GABOB in the livers and
brains of rabbits by perfusing them with the diluted homologous blood. containing
GABOB. The purpose is to know whether GABOB is actually metabolized in
these organs or not, as the metabolic pathway of GABOB is still obscure.
MATERIALS AND METHODS
Thirty-two adult white rabbits, both male and female, weighing about 2kg
were used. These animals were divided into 2 groups, 16 animals including 8
controls in each. Just before the operation about 40 ml. of blood was taken from
each animal from femoral artery inserting polyethylene tube 1mm. in diameter.
Blood was drawn from the tube by using syringe. The accumulated blood was
defibrinated and used for the perfusion of the organs from the same animals.
The livers were excised from the animals belonging to the first group by open-
ing the abdomen without anesthesisa. These liver were put into the chamber of
OHASHI's perfusion apparatus for liver, 37.5°C and the liver were perfused
through the portal vein with the diluted blood by OHASHI's method2• The
animals belonging to the second group were decapitated and the head containing
brains were perfused through both arteria carotis interna with the same solution
as that used for liver perfusion by applying INOUE's methods. For the perfusion
of organs the blood from the same individual was used. The blood was diluted
* The outline of this paper was reported at the 33rd Meeting of the Japan Biochemical Society.
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3·fold with Ringer's solution and 100 milligram per cent of GABOB was added,
and the pH of this diluted blood was adjusted to 7.4 by adding N/10 NaOH. For
perfusion 90 ml. of the diluted blood was used for each experiment, the inflow
pressure was 10 to 15 mmHg and the amount 45 ml. per minute for the liver,
and 20 ml. per minute for the brain. The perfusion was continued for 60 minutes
in the liver and 30 minutes in the brain.
For the control the similar solution without GABOB was perfused under
the same conditions and in the same manner.
Crude material GABOB was donated by ONO Pharmaceutical Co., Ltd.
GABOB used for this experiment was obtained from this material by recrystalli-
zation from the saturated solution adding pure ethanol till this solution became
muddy. This was left standing for 24 hours at 1Qto 5 QC and the supernatant
was decanted. The precipitate was washed with ethanol twice and dried at room
temperature.
Paperchromatography was carried out on the diluted blood used for per-
fusion, before use and after the perfusion test. The diluted blood was deprotei-
nized adding 2 volumes of pure ethanol and was filtrated through filter paper.
0.1 ml. of the deproteinized filtrate was spotted on filter paper, Toyo Roshi
No. 50, 40 X 40, for two-dimensional paperchromatography. Each of two series
of development was prepared for one sample using different solvent systems,
i. e. one for butanol-acetic acid-water (4: 2: 1 v/v) and water saturated phenol,
and the other for ethanol-acetic acid-water (4: 2: 1 v/v) and water saturated
phenol (ammonia gas in the chamber). Qualitative determination of amino acids,
which will be produced in the relation with the metabolism of GABOB, was
made ninhydrine reaction by the routine method. For the quantitative estimation
of amino acids, the one dimensional paperchromatography was carried out. For
GABOB 0.1 ml. deproteinized filtrate of perfusion fluid was developed with
butanol-acetic acid-water (4: 2: 1 v/v) on Toyo Roshi No. 50, 40 X 2, and for
glycine, glutamic acid and glutamine the same amount of the sample was
developed with water saturated phenol. For the performance of the quanti-
taive analysis the developed filter paper was thoroughly dried first and then 0.5
per cent ninhydrine solution was sprayed for the coloration, and colored spots cor-
responding GABOB, glycine, glutamic acid and glutamine were cut apart. Each
sample was cut into slender strips and extracted with 0.2 ml. of 0.1 N NaOH for
24 hours left standing. Then it was neutralized with addition of 0.2 ml. of
0.1 N citric acid. The pH of each extract was adjusted to 5.0 by adding 1 ml.
citrate buffer, and further extracted by shaking for 30 minutes for the complete
extraction. To each of the extracts thus obtained, 2ml. of 2 per cent ninhydrine
solution and 0.2 ml. of tin chloride solution (prepared by dissolving 2 g SnC12
2H20 in 124 ml. citrate buffer) were added and colored by heating in the boiling
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water bath for 20 minutes. Next, it was diluted with addition of 7 ml. of 50 per
cent n-propanol. The absorption intensities were estimated by mean of the
Beckman type spectrophotometer, Shimazu CO., at 410 m!l. for GABOB and
570 mp. for glycine, glutamic acid and glutamine. For drawing the standard
curves, pure GABOB, glycine, glutamic acid and glutamine were employed.
With these the solutions of 0.1, 0.5, 1.0, 5.0, 10.0, 20.0, 30.0 and 40.0 milli-
gram per cent were prepared in each sample.
RESULTS
The organs, both livers and brains, used for the observations showed not
any changes such as swelling, color tone chartge or other changes during or
after perfusion.
Qaulitative analysis:
In the two-dimensional paperchromatography, developed with butanol-acetic
acid-water (4: 2: 1: v/v) and water saturated phenol both of the perfused
fluids from the liver and the brain showed some spots of amino acids. The en-
largement of the color spot of each amino acid, i. e. RI's to be 0.32, 0.32 and
0.44 respectively in butanol-acetic acid-water (4: 2: 1 v/v) and RI's of 0.42,
0.23 and 0.63 in the water saturated phenol. The amount of these amino acid
seemed to be increased in the cases of perfused fluids containing GABOB. In
the paperchromatography of various amino acids developed with the same sol-
vents, glycine, glutamic acid and glutamine gave the RI's of 0.32, 0.32 and
0.44 in butanal-acetic acid-water (4: 2: lv/v) respectively and 0.41, 0.23 and
0.63 with the water saturated phenol. The results indicate that the RI's of
amino acids showing an enlargement of color spots by addition of GABOB in
the perfusion fluid correspond to those of glycine, glutamic acid and glutamine
(Figs. 1, 2). Next, when each of the perfused media was mixed with pure
glycine, glutamic. acid and glutamine respectively and developed on two-dimen-
sional paperchromatography with the same solvent systems, the spots of glycine,
glutamic acid and glutamine were found to be completely superimosed on the
spots of amino acids appeared in the perfused media and enlarged by addition of
GABOB.
Results obtained by using the solvent of ethanol-acetic acid-water (4: 2: 1
v/v) and water saturated phenol (ammonia gas in the chamber) on both of the
fluids perfused the liver and the brain showed also the spots of amino acids and
they appeared enlarging in the case of the perfused fluids containing GABOB.
The similar experiment as mentioned above on these cases proved that these spots
correspond to those of glycine, glutamic acid and glutamine respectively, i. e.
RI's of the amino acids in the fluids perfused liver and brain were 0.16, 0.18
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Fig. 1. Diagrammatical demonstrations of ninhydrine reaction performed on the developed fluids before and
after the perfusions through liver of rabbits.
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Fig. 2. Diagrammatica) demonstrations of ninhydrine reaction performed on the developed fluids before and
after the perfusions through brain of rabbits.
before perfusion (GABOB [-]) before perfusion (GABOB[ +])
G-tG-L.A GL 1+
G-tGL.AGL
+ o 0 o 0
<5 gI=:
1j 1j
0. 0.
"'C 0 Ol>L "'C I 0 OGlL~ ~~ ~ OGABOB'"'E 0 06 E 0 O~1Jl 1Jl
'"' os '"' I OGIL.A~ 0 L.A ~ 0~ ~~ ~
t + + f I + +
-. ~butanol-acetic acid-water butanol-acetic acid-water
Control
before perfusion after perfusion
_G.t..Gl,A GL 1+ G+GL.A GL+ o 0 o 0] g
..c: 1j
0. 0.
"'C 0 06L "'C I 0 OGlL~ ~~ ~
E 0 OG E I 0 OG1Jl ~'"' 0 06 LA '"' 0 OG-lL.A~ ~~ ~~ . ~t+ + 1+ +
.-
-butanol-acetic acid-waterbutanol-acetic acid-water
G : Glycine
GL. A: Glutamic acid
GL : Glutamine
r
8-
-.l
>§.
9
"tb
~
i
::I.
n
;:J>
o.
0..
~
M=>-
Ol
5
Yoshikawa: Studies on &#947;-amino-&#946;-hydroxybutyric acid III. Metabolism of
Produced by The Berkeley Electronic Press, 1961
Fig. 3. Diagrammatical demonstrations of ninhydrine reaction performed on the developed fluids before and
after the perfusions through liver of rabbits.
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Fig. 4. Diagrammatical demonstrations of ninhydrine reaction performed on the developed fluids before and
after the perfusions through brain of rabbits.
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and 0.31 in the ethanol-acetic acid-water (4: 2: 1 v/v) showing the good coin-
cidence with those glycine, glutamic acid and glutamine respectively. In the
cases developed with the solvent of water saturated phenol (ammonia gas in the
chamber), the RI's of the amimo acids found in the perfused media also showed
good coincidence with those of glycine, glutamic acid and glutamine, 0.46,
0.25 and 0.65 respectively (Figs, 3, 4). The observations on the perfused solu-
tions mixed with pure glycine, glutamic acid and glutamine showed the super-
imposed three amino acids on those amino acids found in the perfused media,
identifying the amino acids found in perfused media to be glycine, glutamic and
glutamine
Quantitative analysis:
The quantitative estimation on GABOB on the perfusion media proved that
the added GABOB in the media is reduced by one third of original level after
the perfusicn both through the liver and the brain, as shown in Table 1.
Table 1. Quantitative analysis of GABOB.
Analysis on the fluids perfused liver
Case I hao," I afrer I decrease
No.
perrfusion perfusion (')')(')') (')')
1 34 22.5 11.5
2 26.5 21 5.5
3 32.5 12 20.5
4 32 25 7
5 27 20.5 6.5
I 6 24 21 13
7 33 17 16
8 27.5 15.5 12
average I 30.8 I 19.3 I 11.5
Analysis on the fluids perfused brain
Case I hao," I .frer I
No.
perfusion perfusion decrease
(')') (')')
1 29 18.5 10.5
2 27 19 8
3 28.5 24 4.5
4 31 24 7
5 29.5 17 12.5
6 29 20 9
7 30.5 26.5 4
8 30 22.5 7.5
avesage I 2~.3 I 21.4 I 7.9
Note: Values represent the contents of GABOB in 0.1 ml. of deproteinized filtrate
of perfusion fluid.
As expected from the qualitative observation on the amino acids, the quan-
titative estimation on amino acids proved that the contents of glycine, glutamic
acid and glutamine are increased in the GABOB containing medium after per-
fusion in comparison with the control, i. e. glycine showed a considerable increase
though the increase in glutamic acid and glutamine were slight. The increasing
rates of these amino acid were almost the same both in the fluids perfused liver
and those perfused brain (Tables 2, 3, 4, 5).
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Table 2. Quantitative analysis of glycine, glutamic acid and glutamine.
Analysis on the fluid perfused liver.
149
Glycine
cl c::co ~ c::co ~ Q) Iz ~.~~C ...Q~C '"JZ2<t:~ Q) '" ~~~ .... ;:l ~ .. C'-............ <t:......, u~C':l ~~~~ C':l [lc.:J+ .SU c.~'-'
1 0.3 1.4 1.1
2 0.7 1.5 0.8
3 0.9 2.8 1.9
4 0.3 1.8 1.5
5 0.4 0.6 0.2
6 0.3 0.65 0.35
7 0.6 1.7 1.1
8 0.7 1.55 0.85
ave.! 0.53 I 1.5 1 0.97rage
Glutamic acid
cl §CO ~ C::CO ~ Q)
Z Q)._~~ ...Q~C '".. '" Q) '" ~~
Q) JZ2<t:~ 4::..E<t:~ .. C'-
'" ~[lc.:J1 C':l[lc.:J+ u~C':l .Su c.~_ c.~_
1 0.2 0.5 0.3
2 0.4 1.55 1.15
3 0.3 0.4 0.1
4 0.2 0.35 0.!5
5 0.4 0.7 0:3
6 0.45 0.6 0.15
7 0.5 0.6 0.1
8 0.45 1.1 0.65
ave.! 0.38 I 0.73 1 0.35rage
Glutamine
cl c::co ~ c::co ~ Q)
Z ~·QoC ...Q~C '"o~CO~ ~~ - ~~Q) ............ <t:......, ............ <t:......, .. C'-
'" ~~~~ C':l~~~ u~J .S
1 1.7
I
5.7 4.0
2 5.2 6.1 0.9
3 3.3 5.0 1.7
4 2.3 3.7 1.4
5 4.5 5.7 1.2
6 4.3 5.3 1.0
7 3.6 5.4 1.8
8 I 3.8 5.1 1.3
ave.! 3.6 I 5.3 11.7rage
Note: Values represent the content of amino acids in 0.1 ml. of depoteinized filtrate
of perfusion fluid.
Table 3. Quantitative analysis of glycine, glutamic acid and glutamine.
Analysis on the fluid perfused liver (Control).
Glycine
~ c::co ~ c::~~ Q)~.~~C .. ·QOC ~~JZ2<t:~ ~~co~ .. C'-lIJl ...... 't::<t:......, u~
J ~ [lc.:J I C':l&~~ .Sc.~'-'
1 0.7 0.8 0.1
2 0.35 0.45 0.1
3 0.5 0.55 0.05
4 0.35 0.5 0.15
5 0.9 1.1 0.:'
6 0.4 0.7 0.3
7 0.75 0.9 0.15
8 0.4 0.7 0.3
ave-I 0.54 I 0.71 1 0.17rage
Glutamic acid
cl §CO ~ C::CO ~ Q)
Z ~'iii~~ .. ·QOC '"O;:l ~ ~ ~CO ~ ~~
~ ]'t::<t:" ............ <t:" .. C'-u~C':l &~~ C':l~~~ .SU
1 0.7 1.1 0.4
2 0.3 0.5 0.2
3 0.45 0.5 0.05
4 0.2 0.45 0.25
5 0.3 0.9 0.6
6 0.25 0.4 0.15
7 0.2 0.3 0.1
8 0.3 0.5 0.2
ave-I 0.34 I 0.62 1 0.28rage
Glutamine
~ §CO ~ c::CO ~ ~~._~~ "'iii@~ ~~0'" ~ =' -Q) ..... 2<t:;::;
...... 't::<t:'""' "C'-u~
'" ~[lc.:J1 C':l&~~ .SC':lU c.~'-'
1 4.8 5 0.2
2 4.8 5.2 0.4
3 2.2 2.8 0.6
4 2.3 5.2 2.9
5 2.6 3.8 1.2
6 3.4 4.5 1.1
7 2.1 4.7 2.9
8 3.6 4.2 0.6
ave'l 3.2 I 4.4 I 1.2rage
Note: Value represent the content of amino acids in 0.1 ml. of deproteinized filtrate
of perfusion fluid.
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Table 4. Quantitaive analysis of glycine, glutamic acid and glutamine.
Analysis on the fluid perfusd brain.
Glycine
cS 1:1:0 ~ 1:1:0 ~ ~Z v.2 2!: \.<.22!:\.< '" ~:g - a3~o;:l ~~ 1)'t:<;r-1 '-'t:<;r-1 .~c~ ~~g~ ~ ~g~U
1 0.8 2.2 1.4
2 0.4 0.8 0.4
3 0.4 0.9 0.5
4 0.3 1.5 1.2
5 0.35 1.1 0.75
6 0.5 1.2 0.7
7 0.3 0.9 0.6
8 0.7 1.5 0.8
ave-! 0.47 I 1.26 I 0.79rage
Glutamic acid
cS § 1:0 ;:- 1:1:0 ~ ~z ~'Cii2~ \.<.22 CO;:l ~ ~~ .-. a3--~ '-'_<;r-1 '_'_<r-1 \.<~
.8 &g~ ~ &g~ u~~ .5u
1 0.2 0.5 0.3
2 0.2 0.3 0.1
3 0.3 0.45 0.15
4 0.4 0.7 0.3
5 0.45 1.2 0.75
6 0.5 1.1 0.6
7 0.6 0.9 0.3
8 0.35 0.75 0.4
ave-I 0.38 I 0.74 1 0.36rage
Glutamine
~ § 1:0 t:1 § 1:0 ;:- ~~'Cii2~ \.<·iii2~ a3~O;:l ~ ~::l ~
~ ] 't: < r-1 1,_ 't: < r-1 \.<~u~
u ~g~l~ ~g~ .5
1 2.2 5.0 2.8
2 2.7 5.5 2.8
3 2.5 3.8 1.3
4 3.4 6.0 2.6
5 6.0 7.0 1.0
6 4.7 5.9 1.2
7 4.5 5.6 1.1
8 3.6 4.8 1.2
ave-I 3.7 I 5.45 11.75rage
Note: Value represent the content of amino acids in 0.1 ml. of deproteinized filtrate
of perfusion fluid
Table 5. Quantitative analysis of glycine, glutamic acid and glutamine.
Analysis on the fluid perfused brain (Control).
Glycine
cS § 1:0 ;:-1 g1:0 ;:- Q)
Z ~'CiiO~ \.<·CiiO~ '"o ::l1:O~ ~ ;:l1:O~ a3~
Q) 1) 't: < r-11'_ 't: < r-1 \.<~
'"
u~
ca ~ ~g~ ca ~g~ .5u
1 0.7 0.8 0.1
2 0.35 0.45 0.1
3 0.5 0.55 0.05
4 0.35 0.5 0.15
5 0.8 1.1 0.3
6 0.4 0.7 0.3
7 0.3 0.7 0.4
8 0.5 0.8 0.3
ave-\ 0.49 I 0.7 1 0.21rage
Glutamic acid
~ 1:1:0 ~ 1:1:0 ~ v~'~2C \.<.22 C '"E~ .-. a3;:-
Q) ..£2<;::; '_'_<r-1 \.<~
'" .8 &g~ ca&g~ uca
.5u
1 0.7 1.3 0.6
2 0.3 0.6 0.3
3 0.2 0.5 0.3
4 0.55 0.6 0.05
5 0.2 0.45 0.25
6 0.35 0.55 0.2
7 0.4 0.6 0.2
8 0.25 0.45 0.2
ave-I 0.37 I 0.63 1 0.26 1rage
Glutamine
~ ~.§5E 1:1:0 ~ ~\.<.22 CO"'I:O~ Q) '" a3--~ 1)2<r-1 ~-E<;::; \.<~~~g~ ~ ~g~ u~~
.5u
1 3.8 5.0 1.2
2 4.8 5.2 0.4
3 2.2 5.2 3.0
4 4.2 5.3 1.1
5 2.4 3.8 1.4
6 3.5 4.6 1.1
7 3.8 5.1 1.3
8 4.2 5.3 1.1
ave-I 3.7 I 4.9 I 1.2rage
Note: Value represent the content of amino acids in 0.1 ml. of deproteinized filtrate
of perfusion fluid.
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DISCUSSION
As suggested by SUGIURA et at.', GABOB seems to be converted to r-
aminoacetoacetic acid by oxidation first and then further oxidized decomposing
into glycine and acetic acid. Another way for catabolism may be the fonnation
of glutamic acid and malic acid by the transamination with a-ketoglutaric acid.
OKUMURA et at.UJ, and KONOO7 observed the increased excretion of glycine and
p-alanine in urine after the intravenous injection of r-aminobutyric acid into
rabbits. From these observations it was supposed that r-aminobutyrie acid would
be oxidized to GABOB producing glycine by the way just mentioned and on the
other hand, fi-alanine through r-amino-a-hydroxybutyric acid.
In the perfusion test of liver and brain with the·fluid containing GABOB,
it has been revealed that a quantity of glycine, some glutamic acid and glutamine
are produced by consuming GABOB. This indicates that GABOB will be me-
tabolized to glycine probably passing the stage of r-aminoacetoacetic acid, and
supports the view proposed by SUGIURA et at.', OKUMURA et at.fl •G, and KONOO7•
Thus the possible metabolic pathway of GABOB is as follows:
NH,-CH2-CH-CH,-CCOH -+ (NH,-CH2-eo-CH2·COOH) -+ NH:a-CH:a-COOH
I
OH
GABOB (r-aminoacetoacetic acid) Glycine
However, there is a possibility that GABOB is decomposed by another
metabolic pathway, though it may not be the main way. The increase in
glutamic acid and glutamine in the perfused fluid containing GABOB seems to
suggest the existence of a metabolic pathway where GABOB is converted to
glutamic acid by transamination with a-ketoglutaric acid as suggested by
SUGIURA. The glutamine will be formed from glutamic acd.
CONCLUSION
For the purpose to reveal the metabolic pathway of GABOB the analyses
were performed with the GABOB containing fluid perfused through the liver
and the brain of rabbits, and the following results were obtained.
Qualitative observations by paperchromatography on the fluid containing
GABOB after perfusing the organs proved the presence of some amino acids.
These were identified as glycine, glutamic acid and glutamine. The observation
on the GABOB containing fluid perfused the organs showed a decrease in GABOB
and an increase in these amino acids.
Quantitative observation proved a considerable increase in glycive and a
moderate increase in glutamic acid and glutamine with a marked decrease in
the amount of GABOB injected.
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From these results it is believed that GABOB is decomposed into glycine
and acetic acid probably passing the stage of r-aminoacetoacetic acid in one way
and into glutamic acid by the transamination of GABOB with a-ketoglutaric
acid in the other.
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